PPARG and metabolic syndrome: Some rare missense mutations in PPARγ may cause profound phenotypic changes in affected individuals, contributing to the risk of dyslipidemia, type 2 diabetes [16], and colon cancer [8,13,17,18,19,20,21,22,23].